ACS Pharmacology & Translational Science · 2019 · 48 citations · 34 references
PharmacyOncologyPharmacologyCell SignalingDrug DiscoverySignal TransductionAntifibrotic TherapyCancer-associated FibroblastsFibrosisMelanoma PharmacotherapyTargeted Cancer TherapyAffinity-based Target IdentificationBiologic Antifibrotic AgentsBiophysical AssaysBleomycin InjectionFibroblast ActivationIsothermal Titration CalorimetryLuciferase Reporter AssaysMolecular Target Selection
A series of compounds (including CCG-1423 and CCG-203971) discovered through an MRTF/SRF-dependent luciferase screen has shown remarkable efficacy in a variety of in vitro and in vivo models, including significant reduction of melanoma metastasis and bleomycin-induced fibrosis. Although these compounds are efficacious in these disease models, the molecular target is unknown. Here, we describe affinity isolation-based target identification efforts which yielded pirin, an iron-dependent cotranscription factor, as a target of this series of compounds. Using biophysical techniques including isothermal titration calorimetry and X-ray crystallography, we verify that pirin binds these compounds in vitro. We also show with genetic approaches that pirin modulates MRTF-dependent luciferase reporter activity. Finally, using both siRNA and a previously validated pirin inhibitor, we show a role for pirin in TGF-β-induced gene expression in primary dermal fibroblasts. A recently developed analog, CCG-257081, which cocrystallizes with pirin, is also effective in the prevention of bleomycin-induced dermal fibrosis.
34